Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |